Title:
TWEAK RECEPTOR AGONISTS AS ANTI-ANGIOGENIC AGENTS
Document Type and Number:
WIPO Patent Application WO2002022166
Kind Code:
A9
Abstract:
The present invention relates to methods of modulating angiogenesis and inhibiting tumor progression by using TWEAK receptor (Fn14) agonists. In particular, methods for inhibiting angiogenesis are disclosed.
Inventors:
BROWNING JEFFREY (US)
BURKLY LINDA (US)
JAKUBOWSKI ANIELA (US)
ZHENG TIMOTHY (US)
BURKLY LINDA (US)
JAKUBOWSKI ANIELA (US)
ZHENG TIMOTHY (US)
Application Number:
PCT/US2001/028451
Publication Date:
April 03, 2003
Filing Date:
September 12, 2001
Export Citation:
Assignee:
BIOGEN INC (US)
BROWNING JEFFREY (US)
BURKLY LINDA (US)
JAKUBOWSKI ANIELA (US)
ZHENG TIMOTHY (US)
BROWNING JEFFREY (US)
BURKLY LINDA (US)
JAKUBOWSKI ANIELA (US)
ZHENG TIMOTHY (US)
International Classes:
A61K39/395; A61P1/04; A61K45/00; A61P3/10; A61P7/08; A61P9/00; A61P9/10; A61P9/14; A61P15/00; A61P17/02; A61P19/00; A61P25/04; A61P27/02; A61P29/00; A61P35/00; A61P41/00; A61P43/00; C07K16/28; A61K38/00; (IPC1-7): A61K39/395; A61K38/17; A61P35/00
Download PDF:
Previous Patent: NON-GENETIC BASED PROTEIN DISEASE MARKERS
Next Patent: VACCINE AGAINST STREPTOCOCCUS PENUMONIAE
Next Patent: VACCINE AGAINST STREPTOCOCCUS PENUMONIAE